Skip to main content

Advertisement

Table 3 Clinical characterizations of BRCA1- and MGMT-methylated ovarian cancer patients

From: Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters

Patient no. Age Type Grade BRCA1 MGMT
2 54 Clear cell carcinoma Advanced Meth Meth
13 54 Serous carcinoma High Meth Meth
36 55 Ovarian serous carcinoma High Meth Meth
50 43 Ovarian serous carcinoma. High Meth Meth
23 40 Serous carcinoma High Mut/Meth Meth
38 54 Serous carcinoma ND Mut/Meth Un Meth
7 57 Papillary serous carcinoma High Meth Un Meth
24 53 Serous adenocarcinoma 3 Meth Un Meth
27 47 Serous carcinoma involving uterus High Meth Un Meth
52 67 ovarian adenocarcinoma High Meth Un Meth
59 53 ovarian serous carcinoma High Meth Un Meth
71 38 Ovarian serous carcinoma ND Meth Un Meth
29 47 Carcinoma of the right ovary High Meth Un Meth
6 58 Papillary serous carcinoma High Mut Meth
14 34 Serous adenocarcinoma High Mut Meth
47 65 Poorly differentiated adenocarcinoma ND Mut Meth
17 66 serous ovarian carcinoma ND Mut Meth
69 41 Ovarian serous carcinoma ND Mut Meth
4 38 Clear cell carcinoma GII WT Meth
9 46 papillary serous cancer High WT Meth
16 67 Serous adenocarcinoma High WT Meth
44 88 Metastatic granulosa cell tumor ND WT Meth
55 43 serous carcinoma High WT Meth
60 49 Granulosa cell tumor ND WT Meth
79 44 Mucinous cyst adenocarcinoma ND WT Meth
  1. Meth methylated, Mut mutated, WT wild type, ND no data